Santa Farma İlaç Partners with Advanco to Boost Production Process Efficiency

Santa Farma İlaç, a long-established pharmaceutical company in Turkey, is continuing its strategic partnership with Advanco.

Santa Farma İlaç CEO Sami Kiresepi states, "As Santa Farma İlaç, we continue our operations with the goal of becoming a reference company in the healthcare sector by integrating local needs into global markets at world standards. This partnership we conduct with Advanco enables our processes to be more agile, our global scope to be broader and more controlled, while significantly increasing the value of the services we provide to our customers."

With a rooted history spanning over 80 years in the pharmaceutical sector, Santa Farma İlaç produces high-quality solutions aimed at strengthening human health and continues to make technological partnerships and investments that provide production standards on a global scale.

Santa Farma İlaç, which has been continuing its partnership with Advanco, a technology company that provides world-scale solutions in serialization and traceability for the pharmaceutical sector, since 2015, is increasing the reliability and efficiency of its production processes through Advanco's ARC system.
With Santa Farma İlaç's transition to a CDMO (Contract Development and Manufacturing Organization) structure, the importance of this partnership with Advanco increases further, while also contributing to the company's next-generation production targets. As one of Turkey's leading pharmaceutical manufacturers with 127 products in 10 different therapeutic areas, Santa Farma İlaç contributes to the global healthcare sector and stands out with its investments in advanced technology across a wide range.

CEO Sami Kiresepi: Our new vision is 'to be a reference company in healthcare that brings together local needs in global markets with global standards'
"As Santa Farma İlaç, we continue our operations with the goal of becoming a reference company in the healthcare sector by integrating local needs into global markets at world standards. At the same time, we always maintain our visionary approach in taking forward-looking steps to ensure sustainable and quality production in a continuously evolving sector. For Santa Farma İlaç, ensuring reliability, transparency and full compliance with regulations in pharmaceutical manufacturing has always been a priority," CEO Sami Kiresepi said, adding the following regarding the partnership conducted with Advanco:

"The partnership we initiated with Advanco in 2015 is not merely a technical integration, but also an important strategic partnership in terms of shaping future production standards. Thanks to the advanced traceability solutions provided by Advanco, we are making our production processes more efficient while reinforcing our commitment to global standards compliance. This partnership plays a critical role in Santa Farma İlaç's transition to CDMO structure and makes our processes more agile, our digital network scope broader and more controlled, while increasing the value of the services we provide to both our local and global customers. I believe this partnership will strengthen and continue over many years and will serve as an example to the sector."